Investigation Overview
Jan. 30, 2013 (Shareholders Foundation) -- An investigation on behalf of investors in BioClinica Inc (NASDAQ:BIOC) shares was announced concerning whether the offer by JLL Partners, Inc to acquire BioClinica Inc for $7.25 per NASDAQ:BIOC share and the takeover process are unfair to investors in NASDAQ:BIOC shares. The investigation by a law firm concerns whether certain officers and ...
You must register (for free) or login to view the entire investigation.